H. Berna Beverloo

17.4k citations

141 papers · 10.7k · 3 hit papers · h-index 52

Impact in

Hematology top 0.05%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Genetics top 0.5%

Papers in

Hematology 76
- Acute Myeloid Leukemia Research 57
- Chronic Myeloid Leukemia Treatments 33
Public Health, Environmental and Occupational Health 57
- Acute Lymphoblastic Leukemia research 57

Co-authors: Ellen van Drunen (25 shared papers)Rob Pieters (49 shared papers)Bob Löwenberg (15 shared papers)Peter J.M. Valk (20 shared papers)Claudia A. J. Erpelinck-Verschueren (12 shared papers)Ruud Delwel (12 shared papers)Peter J. van der Spek (6 shared papers)Roland Kanaar (4 shared papers)
Journals: Blood (25 papers)Leukemia (22 papers)Genes Chromosomes and Cancer (13 papers)Haematologica (11 papers)British Journal of Haematology (6 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

H. Berna Beverloo

138 papers receiving 10.3k citations

H. Berna Beverloo's Hit Papers

align trajectories log scale

Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome 2022 · 192 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2022 Blood
2009 The Lancet Oncology
2004 New England Journal of Medicine

Peers

Countries citing papers authored by H. Berna Beverloo

Since Specialization

Citations

This map shows the geographic impact of H. Berna Beverloo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Berna Beverloo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Berna Beverloo more than expected).

Fields of papers citing papers by H. Berna Beverloo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Berna Beverloo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Berna Beverloo. The network helps show where H. Berna Beverloo may publish in the future.

Co-authors

The 25 scholars most cited alongside H. Berna Beverloo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H. Berna Beverloo Line = papers co-authored together H. Berna Beverloo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Prognostically Useful Gene-Expression Profiles in Acute Myeloid Leukemia New England Journal of Medicine ·Peter J.M. Valk, Roel G.W. Verhaak, M. Antoinette Beijen, Claudia A. J. Erpelinck-Verschueren, Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Judith M. Boer, H. Berna Beverloo, Michael J. Moorhouse, Peter J. van der Spek, Bob Löwenberg, Ruud Delwel Hit paper breakdown →	2004	1066
2	A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study The Lancet Oncology ·Monique L. den Boer, Marjon van Slegtenhorst, Renée X. de Menezes, Meyling Hua-Chen Cheok, Jessica GCAM Buijs-Gladdines, Susan T.C.J.M. Peters, Laura JCM Van Zutven, H. Berna Beverloo, Peter J. van der Spek, G. Escherich, Martin A. Horstmann, Gritta E Janka-Schaub, Willem A. Kamps, William Edward Evans, Rob Pieters Hit paper breakdown →	2009	692
3	Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells Proceedings of the National Academy of Sciences ·Ate Loonstra, Marc Vooijs, H. Berna Beverloo, Bushra Al Allak, Ellen van Drunen, Roland Kanaar, Anton J. M. Berns, Jos Jonkers	2001	484
4	Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype Journal of Clinical Oncology ·Dimitri A. Breems, Wim L.J. van Putten, Georgine E. de Greef, Shama L. van Zelderen‐Bhola, Klasien B.J. Gerssen‐Schoorl, Clemens H. M. Mellink, Aggie W. M. Nieuwint, Martine Jotterand, Anne Hagemeijer, H. Berna Beverloo, Bob Löwenberg	2008	431
5	The Structure-Specific Endonuclease Ercc1-Xpf Is Required To Resolve DNA Interstrand Cross-Link-Induced Double-Strand Breaks Molecular and Cellular Biology ·Laura J. Niedernhofer, Hanny J.H.M. Odijk, Magda Budzowska, Ellen van Drunen, Alex Maas, Arjan F. Theil, Jan de Wit, N.G.J. Jaspers, H. Berna Beverloo, Jan H.J. Hoeijmakers, Roland Kanaar	2004	416
6	The structure-specific endonuclease Mus81 contributes to replication restart by generating double-strand DNA breaks Nature Structural & Molecular Biology ·Katsuhiro Hanada, Magda Budzowska, Sally L. Davies, Ellen van Drunen, Hideo Onizawa, H. Berna Beverloo, Alex Maas, Jeroen Essers, Ian David Hickson, Roland Kanaar	2007	314
7	Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin Clinical Cancer Research ·Bastiaan Evers, Rinske Drost, Eva Schut, Michiel de Bruin, Eline van der Burg, Patrick W.B. Derksen, Henne H. Holstege, Xiaoling Liu, Ellen van Drunen, H. Berna Beverloo, Graeme C.M. Smith, Niall M.B. Martin, Alan Lau, Mark J. O’Connor, Jos Jonkers	2008	277
8	A Functional Role for Tumor Cell Heterogeneity in a Mouse Model of Small Cell Lung Cancer Cancer Cell ·Joaquim Calbó, Erwin H. N. van Montfort, Natalie Proost, Ellen van Drunen, H. Berna Beverloo, Ralph Leo Johan Meuwissen, Anton J. M. Berns	2011	275
9	Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling Haematologica ·Roeland G. W. Verhaak, Bas J. Wouters, Claudia A. J. Erpelinck-Verschueren, Sakina Abbas, H. Berna Beverloo, Sanne Lugthart, Bob Löwenberg, R Delwel, Peter J.M. Valk	2008	263
10	ERCC1-XPF Endonuclease Facilitates DNA Double-Strand Break Repair Molecular and Cellular Biology ·Anwaar Ahmad, Andria Rasile Robinson, Anette U. Duensing, Ellen van Drunen, H. Berna Beverloo, David B. Weisberg, Paul Hasty, Jan H.J. Hoeijmakers, Laura J. Niedernhofer	2008	242
11	NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern Blood ·Iris H.I.M. Hollink, den Heuvel M. van, Susan T.C.J.M. Arentsen-Peters, Marta Pratcorona, Saman Abbas, Jenny E. Kuipers, Janneke F. van Galen, H. Berna Beverloo, Edwin Sonneveld, Gertjan J.L. Kaspers, Jan Trka, André Baruchel, Martin A. Zimmermann, Ursula Creutzig, Dirk Reinhardt, Rob Pieters, Peter J.M. Valk, Christian Michel Zwaan	2011	239
12	Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients Blood ·Annemiek Broyl, Dirk Hose, Henk M. Lokhorst, Yvonne de Knegt, Justine K. Peeters, Anna Sophia Jauch, Uta Bertsch, Arjan Buijs, Marian Stevens‐Kroef, H. Berna Beverloo, Edo Vellenga, Sonja Zweegman, Marie-Josée Kersten, Bronno van der Holt, Laila el Jarari, George Mulligan, Hartmut Goldschmidt, Mark van Duin, Pieter Sonneveld	2010	235
13	High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated Blood ·Sanne Lugthart, Ellen van Drunen, Yvette van Norden, Antoinette van Hoven, Claudia A. J. Erpelinck-Verschueren, Peter J.M. Valk, H. Berna Beverloo, Bob Löwenberg, Ruud Delwel	2008	233
14	Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia Nature Genetics ·Idoya Lahortiga, Kim De Keersmaecker, Pieter Van Vlierberghe, Carlos Graux, Barbara Cauwelier, Frédéric Lambert, Nicole Mentens, H. Berna Beverloo, Rob Pieters, Frank Speleman, Maria Dolores Odero, Marijke Bauters, Guy Froyen, Peter Marynen, Peter Vandenberghe, Iwona Włodarska, Jules P.P. Meijerink, Jan Cools	2007	212
15	Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML The Hematology Journal ·Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Claudia A. J. Erpelinck-Verschueren, Joost M. R. Meijer, Susanna van Oosterhoud, Wim L.J. van Putten, Peter J.M. Valk, H. Berna Beverloo, Daniel Geoffrey Tenen, Bob Löwenberg, Ruud Delwel	2003	197
16	Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome Blood ·Tim Grob, Adil S. A. Al Hinai, Mathijs Arnoud Sanders, François G. Kavelaars, Melissa Rijken, Patrycja L. Gradowska, Bart J. Biemond, Dimitri A. Breems, Johan A. Maertens, Marinus van Marwijk Kooy, Thomas Pabst, Okke de Weerdt, Gert Jan Ossenkoppele, Arjan A. van de Loosdrecht, Gerwin A Huls, Jan J. Cornelissen, H. Berna Beverloo, Bob Löwenberg, Mojca Jongen‐Lavrencic, Peter J.M. Valk Hit paper breakdown →	2022	192
17	Genomic and Expression Profiling of Human Spermatocytic Seminomas: Primary Spermatocyte as Tumorigenic Precursor and DMRT1 as Candidate Chromosome 9 Gene Cancer Research ·Leendert H. J. Looijenga, Remko Hersmus, Ad Gillis, Rolph Pfundt, Hans Stoop, Ruud J. H. L. M. van Gurp, Joris A. Veltman, H. Berna Beverloo, Ellen van Drunen, Ad Geurts van Kessel, Renee A. Reijo Pera, Dominik T. Schneider, Brenda M. Summersgill, JANET M. SHIPLEY, Alan McIntyre, Peter J. van der Spek, Eric Schoenmakers, J. Wolter Oosterhuis	2006	188
18	The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia Blood ·Pieter Van Vlierberghe, Martine van Grotel, Joëlle Tchinda, Charles Lee, H. Berna Beverloo, Peter J. van der Spek, Andrew Stubbs, Jan Cools, Kyosuke Nagata, Maarten W.J. Fornerod, Jessica G. C. A. M. Buijs-Gladdines, Martin A. Horstmann, Elisabeth R. van Wering, Jean Pierre Soulier, Rob Pieters, Jules P.P. Meijerink	2008	174
19	Mouse RAD54 Affects DNA Double-Strand Break Repair and Sister Chromatid Exchange Molecular and Cellular Biology ·Mies L. G. Dronkert, H. Berna Beverloo, Roger D. Johnson, Jan H.J. Hoeijmakers, Maria Jasin, Roland Kanaar	2000	146
20	The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia Blood ·Pieter Van Vlierberghe, Martine van Grotel, H. Berna Beverloo, Charles Lee, Thorunn Helgason, Jessica G. C. A. M. Buijs-Gladdines, Monique Passier, E R van Wering, (unknown), W. A. Kamps, Jules P.P. Meijerink, Rob Pieters	2006	136

About H. Berna Beverloo

H. Berna Beverloo is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Genetics, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 141 papers that have together received 10.7k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (57 papers), Acute Myeloid Leukemia Research (57 papers), Chronic Myeloid Leukemia Treatments (33 papers), Protein Degradation and Inhibitors (15 papers), Chronic Lymphocytic Leukemia Research (15 papers), Childhood Cancer Survivors' Quality of Life (11 papers), Epigenetics and DNA Methylation (11 papers) and DNA Repair Mechanisms (9 papers). The work is most often cited by research in Hematology (5.0k citations), Genetics (1.1k citations), Public Health, Environmental and Occupational Health (2.7k citations), Cancer Research (1.1k citations) and Molecular Biology (5.3k citations). H. Berna Beverloo has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Ellen van Drunen, Rob Pieters, Bob Löwenberg, Peter J.M. Valk, Claudia A. J. Erpelinck-Verschueren, Ruud Delwel, Peter J. van der Spek, Roland Kanaar, Jules P.P. Meijerink and Sahar Barjesteh van Waalwijk van Doorn-Khosrovani. Their work appears in journals such as Blood, Leukemia, Genes Chromosomes and Cancer, Haematologica and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

H. Berna Beverloo

Impact in

Papers in i

In The Last Decade

H. Berna Beverloo

H. Berna Beverloo's Hit Papers

Peers

Countries citing papers authored by H. Berna Beverloo

Fields of papers citing papers by H. Berna Beverloo

All Works

About H. Berna Beverloo

Explore authors with similar magnitude of impact

Papers in